NYSE:NVS - Novartis Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$90.51 -0.23 (-0.25 %)
(As of 02/22/2019 02:01 AM ET)
Previous Close$90.74
Today's Range$90.21 - $90.79
52-Week Range$72.30 - $92.39
Volume806,105 shs
Average Volume2.06 million shs
Market Capitalization$209.08 billion
P/E Ratio17.78
Dividend Yield2.10%

Analyst Ratings

Novartis (NYSE:NVS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
15 Wall Street analysts have issued ratings and price targets for Novartis in the last 12 months. Their average twelve-month price target is $89.2467, suggesting that the stock has a possible downside of 1.40%. The high price target for NVS is $105.00 and the low price target for NVS is $74.71. There are currently 3 sell ratings, 5 hold ratings, 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.402.00
Ratings Breakdown: 3 Sell Rating(s)
5 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
3 Sell Rating(s)
5 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $89.2467$89.2467$74.71$91.00
Price Target Upside: 1.40% downside1.57% upside14.86% downside12.40% upside

Novartis (NYSE:NVS) Consensus Price Target History

Price Target History for Novartis (NYSE:NVS)

Novartis (NYSE:NVS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/29/2019JPMorgan Chase & Co.Reiterated RatingSellLowView Rating Details
12/20/2018Credit Suisse GroupDowngradeSellLowView Rating Details
12/11/2018Jefferies Financial GroupReiterated RatingBuy ➝ Buy$105.00LowView Rating Details
12/7/2018BarclaysDowngradeEqual Weight ➝ SellLowView Rating Details
12/2/2018CowenUpgradeMarket Perform ➝ Outperform$88.03LowView Rating Details
11/16/2018Goldman Sachs GroupUpgradeNeutral ➝ Conviction-BuyLowView Rating Details
10/23/2018Wolfe ResearchInitiated CoverageOutperformMediumView Rating Details
10/8/2018GuggenheimInitiated CoverageNeutral ➝ NeutralLowView Rating Details
9/11/2018BNP ParibasUpgradeUnderperform ➝ NeutralLowView Rating Details
9/11/2018Exane BNP ParibasUpgradeUnderperform ➝ NeutralLowView Rating Details
9/11/2018CitigroupUpgradeNeutral ➝ BuyLowView Rating Details
9/10/2018Bank of AmericaUpgradeUnderperform ➝ Buy$74.71LowView Rating Details
7/19/2018DZ BankReiterated RatingBuyLowView Rating Details
5/29/2018HSBCDowngradeBuy ➝ HoldLowView Rating Details
4/20/2018Deutsche BankReiterated RatingNeutralLowView Rating Details
1/15/2018UBS GroupReiterated RatingNeutralLowView Rating Details
1/2/2018Nord/LBReiterated RatingNeutralMediumView Rating Details
10/23/2017Leerink SwannBoost Price TargetMarket Perform$89.00 ➝ $91.00N/AView Rating Details
7/26/2017Morgan StanleyUpgradeUnderweight ➝ OverweightLowView Rating Details
3/9/2017Liberum CapitalInitiated CoverageBuy ➝ BuyLowView Rating Details
3/7/2017Societe GeneraleUpgradeHold ➝ Buy$73.82 ➝ $74.37N/AView Rating Details
(Data available from 2/22/2017 forward)
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel